Arcutis Biotherapeutics, Inc. (ARQT)
24.79
-0.29
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Total Assets (Quarterly) : 488.54M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 488.54M |
| March 31, 2026 | 460.00M |
| December 31, 2025 | 432.97M |
| September 30, 2025 | 370.98M |
| June 30, 2025 | 352.43M |
| March 31, 2025 | 344.10M |
| December 31, 2024 | 348.89M |
| September 30, 2024 | 437.35M |
| June 30, 2024 | 444.76M |
| March 31, 2024 | 478.54M |
| December 31, 2023 | 341.36M |
| September 30, 2023 | 292.96M |
| June 30, 2023 | 320.69M |
| March 31, 2023 | 379.46M |
| December 31, 2022 | 449.27M |
| September 30, 2022 | 508.91M |
| Date | Value |
|---|---|
| June 30, 2022 | 300.46M |
| March 31, 2022 | 364.11M |
| December 31, 2021 | 408.15M |
| September 30, 2021 | 387.01M |
| June 30, 2021 | 432.89M |
| March 31, 2021 | 471.42M |
| December 31, 2020 | 298.27M |
| September 30, 2020 | 198.01M |
| June 30, 2020 | 231.97M |
| March 31, 2020 | 254.39M |
| December 31, 2019 | 107.01M |
| September 30, 2019 | 28.30M |
| June 30, 2019 | 38.18M |
| March 31, 2019 | |
| December 31, 2018 | 51.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Insmed, Inc. | 2.103B |
| Emergent BioSolutions, Inc. | 1.117B |
| Exelixis, Inc. | 2.494B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 267.96M |
| Shareholders Equity (Quarterly) | 220.58M |
| Debt to Equity Ratio | 0.5174 |
| Current Ratio | 2.917 |
| Net Debt Paydown Yield | -0.02% |